LUTEOSKYRIN
UNII X3VHC7Q8G9

Substance Identification & Data

This profile provides standardized clinical and technical data for Luteoskyrin, uniquely identified by the FDA Unique Ingredient Identifier (UNII) X3VHC7Q8G9.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 21884-44-6 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

X3VHC7Q8G9

CAS Registry Number

21884-44-6

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

LUTEOSKYRIN

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C30H22O12

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

KXNUPFFSGSRABD-TZRHFUAUSA-N

Line notation for describing the chemical structure and connectivity of atoms.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

[C@@]123[C@@]4([C@]5([C@@]6(C(c7c(c(C)cc(c7C(C6=C([C@@]1([C@@H]5O)[H])O)=O)O)O)=O)[C@@]([C@@H]4O)(C(O)=C3C(c8c(cc(c(c8C2=O)O)C)O)=O)[H])[H])[H]

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Luteoskyrin. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

Common Names & Synonyms

(1.BETA.,1'.BETA.,3.BETA.,3'.BETA.)-8,8'-DIHYDROXY-RUGULOSIN

8,8'-DIHYDROXY-RUGULOSIN

FLAVOMYCELIN [HSDB]

LUTEOSKYRIN

LUTEOSKYRIN [IARC]

Systematic Nomenclature

2,2',3,3'-TETRAHYDRO-2,2',4,4',5,5',8,8'-OCTAHYDROXY-7,7'- DIMETHYL-(1,1'-BIANTHRACENE)-9,9',10,10'-TETRONE

SYS

2,2',4,4'5,5',8,8'-OCTAHYDROXY-2,2',3,3'-TETRAHYDRO-7,7'- DIMETHYL-1,1'-BIANTHRAQUINONE

SYS

5H,6H-6,13A,5A,14-(1,2,3,4)BUTANETETRAYLCYCLOOCTA(1,2-B:5,6- B')DINAPHTHALENE-5,8,13,16(14H)-TETRONE, 1,4,7,9,12,15,17,20-OCTAHYDROXY-3,11-DIMETHYL-

SYS

5H,6H-6,13A,5A,14-(1,2,3,4)BUTANETETRAYLCYCLOOCTA(1,2-B:5,6-B')DINAPHTHALENE-5,8,13,16(14H)-TETRONE, 1,4,7,9,12,15,17,20-OCTAHYDROXY-3,11-DIMETHYL-

SYS

5H,6H-6,13A,5A,14-(1,2,3,4)BUTANETETRAYLCYCLOOCTA(1,2-B:5,6-B')DINAPHTHALENE-5,8,13,16(14H)-TETRONE, 1,4,7,9,12,15,17,20-OCTAHYDROXY-3,11-DIMETHYL-, (5AR-(5AR*,6S*,13AR*,14S*,17R*,18S*,19S*,20R*))-

SYS

5H,6H-6,13A,5A,14-(1,2,3,4)BUTANETETRAYLCYCLOOCTA(1,2-B:5,6-B')DINAPHTHALENE-5,8,13,16(14H)-TETRONE, 1,4,7,9,12,15,17,20-OCTAHYDROXY-3,11-DIMETHYL-, (5AR,6S,13AR,14S,17R,18S,19S,20R)-

SYS

LUTEOSKYRIN, (-)-

SYS

RUGULOSIN, 8,8'-DIHYDROXY-

SYS

RUGULOSIN, 8,8'-DIHYDROXY-, (1S,1'S,2R,2'R,3S,3'S,9AR,9'AR)-

SYS